Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Uxin (UXIN) Shares Outstanding (2016 - 2025)

Uxin filings provide 10 years of Shares Outstanding readings, the most recent being $9.2 billion for Q4 2025.

  • On a quarterly basis, Shares Outstanding rose 16.61% to $9.2 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $9.2 billion, a 16.61% increase, with the full-year FY2025 number at $9.2 billion, up 16.61% from a year prior.
  • Shares Outstanding hit $9149.3 billion in Q4 2025 for Uxin, up from $7.9 billion in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $9149.3 billion in Q4 2025 to a low of $171.6 million in Q1 2021.
  • Median Shares Outstanding over the past 5 years was $4.0 billion (2024), compared with a mean of $1527.6 billion.
  • Biggest five-year swings in Shares Outstanding: increased 8.97% in 2022 and later surged 3723.37% in 2024.
  • Uxin's Shares Outstanding stood at $171.6 million in 2021, then increased by 8.97% to $187.0 million in 2022, then rose by 10.28% to $206.2 million in 2023, then surged by 3707.09% to $7.9 billion in 2024, then increased by 16.61% to $9.2 billion in 2025.
  • The last three reported values for Shares Outstanding were $9.2 billion (Q4 2025), $7.9 billion (Q4 2024), and $7.9 billion (Q1 2024) per Business Quant data.